Potent and Selective Oral STAT6 Degraders Inhibit IL-4 and IL-13 Functions in Human Cells and Block TH2 Inflammation In Vivo in a Mouse Model

May 21, 2024

Potent and Selective Oral STAT6 Degraders Inhibit IL-4 and IL-13 Functions in Human Cells and Block TH2 Inflammation In Vivo in a Mouse Model

Digestive Disease Week (DDW) 2024

Amy Wang, Bin Yang, Anand Ramanathan, Alamgir Hossain, Huijun Dong, Bruce Follows, Chris Browne, Andreas Harsch, Ralf Schmidt, Mike Weis, Rupa Sawant, Bradley Enerson, Jing Yuan, Anthony Slavin, Juliet Williams, Nello Mainolfi

Kymera Therapeutics DDW Poster Picture May 2024
Area of Focus
Immunology
Programs
STAT6 (KT-621)
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link